Michael Karsy
Neurosurgery
1200 E. Michigan Ave., Suite 340
Lansing, MI 48912
Manage Your Profile
About
I am a Clinical Assistant Professor of Neurosurgery at the University of Michigan. I completed my undergraduate degree with honors in Neuroscience at the University of California Los Angeles and a combined MD/PhD program at New York Medical College. I then completed residency in neurosurgery at the University of Utah under Dr. William Couldwell in 2020 with enfolded fellowship in Complex Spine Surgery with Dr. Andrew Dailey and Dr. Erica Bisson as well as a Masters of Bioengineering in Medical Device Development. I then completed a Skull Base fellowship at Thomas Jefferson University Hospital under Dr. James Evans in 2021.
I practice at both the University of Michigan Health – Sparrow and University of Michigan Health – Ann Arbor. My primary focus is on neuro-oncology and skull base pathologies with specialization in endoscopic and minimally invasive approaches. I works as part of a large multi-disciplinary team managing neuro-oncology issues (e.g., pituitary adenomas, meningiomas, gliomas, vestibular schwannomas, metastatic disease). I also have an interest in spine management (e.g., minimally invasive spine surgery, cervical myelopathy, spine tumors, trauma, deformity). My role also involves serving as the Director of Clinical Operations and Quality at University of Michigan Health – Sparrow and previously served as faculty at the University of Utah and Drexel University College of Medicine.
Links
Personal and lab website youtube Department website Google Scholar linkedin ResearchGate Twitter/X
Qualifications
-
Fellowship in Skull BaseThomas Jefferson University Hospital, Neurosurgery, Philadelphia, USA
2020 - 2021
Clinical Fellowship
-
Neurosurgical ResidencyUniversity of Utah Health Care, Neurosurgery, Salt Lake City, United States
2013 - 2020
Residency
-
Fellowship in SpineUniversity of Utah Health Care, Neurosurgery, Salt Lake City, United States
2018 - 2019
Clinical Fellowship
-
MScUniversity of Utah, Salt Lake City, United States
2016 - 2017
-
MD/PhDNew York Medical College, Valhalla, United States
2006 - 2013
Research Overview
My research interests are in molecular characterization and targeted therapy of skull base pathologies, multi-institutional collaboration to advance skull base research, improving healthcare outcomes, and reducing surgical complications through improved integration of techniques and technology in neurosurgery. I have proudly worked on over 190 publications, 11 book chapters, and a surgical textbook. I have participated as a co-investigator and principal investigator on multiple clinical trials in neurosurgical trauma, critical care, and neuro-oncology. I enjoy working with medical students, residents, and fellows both locally and nationally in a variety of research endeavors. I am currently active in the North American Skull Base Society among areas of organized neurosurgery and serve on the research committee I also serve on steering committee member of Registry on Pituitary Adenomas and Related Disorders (RAPID) which is a multi-center consortium involved in clinical and translational research of skull base pathologies.
Recent Publications
-
Demir E, Rahmanipour E, Ghorbani M, Gupta K, Zeinali M, Karsy M. Molecular Biology Reports, 2026 Dec 1; 53 (1):Journal ArticleNeutrophils in glioblastoma: orchestrators of the tumor microenvironment and immune evasion
DOI:10.1007/s11033-026-11525-3 PMID: 41632336 -
Ghorbani M, Tabachnick D, Rahmanipour E, Tavasol A, Gupta K, Pahlevani M, Daskareh M, Sani GG, Karsy M. Clinical Neurology and Neurosurgery, 2026 Oct 1; 269:Journal ArticleImpact of the COVID-19 pandemic on ischemic stroke hospitalizations and in-hospital outcomes in the United States: A survey-weighted cohort with predictive modeling
DOI:10.1016/j.clineuro.2026.109563 -
Rawson C, Kashlan Z, Lucke-Wold B, Karsy M, Pahlevani M. Journal of Vascular Diseases, 2026 Jul 30; 5 (4): 31 - 31.Journal ArticleIs Demonstration of ICH Stability by Repeated Cerebral Imaging Useful Enough to Start DVT Chemoprophylaxis After 24–48 Hours?
DOI:10.3390/jvd5040031 -
Al-Nuaimy Y, Baloi D, Rawson C, Demir E, Qoorchi Moheb Seraj F, Farahnak D, Sarathy D, Sorrentino Z, Lucke-Wold B, Karsy M, Pahlevani M. Journal of Vascular Diseases, 2026 Jul 29; 5 (4): 30 - 30.Journal ArticleCurrent Treatment Paradigms for Giant Thrombotic Intracranial Aneurysms: A Systematic Review
DOI:10.3390/jvd5040030 -
Saloum A, Irshaid A, Rawson C, Mittal A, Karsy M, Pahlevani M, Barber A, Campbell D, Diprose W, Lucke-Wold B. 2026 Jul 22; a105 - a106.Proceeding / Abstract / PosterE-028 Cooling strategies integrated with endovascular thrombectomy for acute ischemic stroke: feasibility, safety, and clinical outcomes
DOI:10.1136/jnis-2026-snis.132 -
Gupta K, Karsy M, Lucke-Wold B, Altschul D. 2026 Jul 22; a199.2 - a1a200.Proceeding / Abstract / PosterE-173 Flow diversion alone versus flow diversion with adjunctive coiling in aneurysmal subarachnoid hemorrhage: a nationwide analysis of the 2018-2022 national inpatient sample
DOI:10.1136/jnis-2026-snis.277 -
Gupta K, Karsy M, Lucke-Wold B, Altschul D. 2026 Jul 22; a200 - a201.Proceeding / Abstract / PosterE-174 Racial, socioeconomic, and COVID-era patterns in treatment modality for unruptured intracranial aneurysms in the united states, 2018-2022
DOI:10.1136/jnis-2026-snis.278 -
Gupta K, Karsy M, Lucke-Wold B, Altschul D. 2026 Jul 22; a211.2 - a2a212.Proceeding / Abstract / PosterE-194 Facility segregation, race, and care intensity after treated aneurysmal subarachnoid hemorrhage in the United States, 2018-2022
DOI:10.1136/jnis-2026-snis.298